Evan Y. Yu

Also affiliated with Fred Hutch Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “Systematic design and data-driven evaluation of social determinants of health ontology (SDoHO)”.

Systematic design and data-driven evaluation of social determinants of health ontology (SDoHO)

Journal of the American Medical Informatics Association(2023)10.1093/jamia/ocad096

N/A

0.713DataRank · unranked

25 citations

Fang Li, Xinyue Hu, Vipina K. Keloth, Meng Zhang, Sunyang Fu +9 more

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.06.001

N/A

0.505DataRank · unranked

28 citations

Rafee Talukder, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +47 more

Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0069

N/A

0.288DataRank · unranked

5 citations

Roman Gulati, Erolcan Sayar, Radhika A. Patel, Pushpa Itagi, Helen Richards +25 more

Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.024

N/A

0.165DataRank · unranked

2 citations

Elizabeth Koehne, Jenna Voutsinas, Leonidas Nikolaos Diamantopoulos, Dimitrios Makrakis, Petros Grivas +19 more

Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.63

N/A

0DataRank · unranked

2 citations

Catherine H. Marshall, Rebeca Lozano, Petros Grivas, Celestia S. Higano, Tamara L. Lotan +11 more

Impact of DNA damage repair (DDR) mutations on treatment outcomes in men receiving conventional therapy for metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.172

N/A

0DataRank · unranked

2 citations

Rigo I. Acevedo, Daniel M. Lim, Roman Gulati, Evan Y. Yu, Michael T. Schweizer +1 more

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of androgen deprivation (AD) +/- cixutumumab, in new metastatic hormone-sensitive prostate cancer (mHSPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.106

N/A

0DataRank · unranked

0 citations

Mai T. Duong, Catherine M. Tangen, Neeraj Agarwal, Heather H. Cheng, Nicholas J. Vogelzang +5 more

Histologic subtype and response to immune checkpoint inhibitor (ICI) therapy in advanced urothelial cancer (aUC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.495

N/A

0DataRank · unranked

0 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002903

N/A

0DataRank · unranked

67 citations

Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard J. Appleman, Paul Monk +18 more

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

British Journal of Urology(2021)10.1111/bju.15324

N/A

0DataRank · unranked

28 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +41 more

Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687.

PubMed(2021)10.3390/tomography7020013

N/A

0DataRank · unranked

7 citations

Finbarr O’Sullivan, Timothy Perk, John P. Muzi, David A. Mankoff, Robert Jeraj +3 more

Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

British Journal of Urology(2021)10.1111/bju.15603

N/A

0DataRank · unranked

5 citations

Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +42 more

Phase III study of local or systemic therapy INtensification DIrected by PET in prostate CAncer patients with post-prostaTEctomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5098

N/A

0DataRank · unranked

3 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Daniel H. Shevrin +10 more

PET-directed local or systemic therapy intensification in prostate cancer patients with post-prostatectomy biochemical recurrence: A trial of the ECOG-ACRIN Cancer Research Group (EA8191).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps267

N/A

0DataRank · unranked

2 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Daniel H. Shevrin +10 more

Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00636-0

N/A

0DataRank · unranked

23 citations

Roman Gulati, Todd Yezefski, Heather H. Cheng, Elahe A. Mostaghel, Michael C. Haffner +17 more

Toward a standard formal semantic representation of the model card report

BMC Bioinformatics(2022)10.1186/s12859-022-04797-6

N/A

0DataRank · unranked

18 citations

Licong Cui, Degui Zhi, Kirk Roberts, Xiaoqian Jiang, Fang Li +3 more

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.08.006

N/A

0DataRank · unranked

9 citations

Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +49 more

Longitudinal screening for depression and anxiety in prostate cancer (PC) and association with disease and treatment factors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5023

N/A

0DataRank · unranked

1 citations

Heather H. Cheng, Jesse R. Fann, James Hnida, Marty Chakoian, Yael Schenker +3 more

Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.05.014

N/A

0DataRank · unranked

33 citations

Funda Vakar‐Lopez, Martine P. Roudier, José M. Garcia, Sonali Arora, Heather H. Cheng +10 more

Clinical, pathologic, and molecular features of amphicrine prostate cancer

The Prostate(2023)10.1002/pros.24497

N/A

0DataRank · unranked

25 citations

Michael C. Haffner, Erolcan Sayar, Agnes Gawne, Michael T. Schweizer, Colin C. Pritchard +4 more

PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5055

N/A

0DataRank · unranked

6 citations

George Mo, Michael C. Haffner, Colm Morrissey, Gavin Ha, Evan Y. Yu +9 more

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates

Research Square(2023)10.21203/rs.3.rs-3745991/v1

N/A

0DataRank · unranked

4 citations

Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman +22 more

Final results of a pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the homologous recombination DNA repair pathway.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5054

N/A

0DataRank · unranked

2 citations

Makayla DeJong, Evan Y. Yu, Roman Gulati, Matthew B. Rettig, Peter S. Nelson +4 more

RefAI: a GPT-powered retrieval-augmented generative tool for biomedical literature recommendation and summarization

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae129

N/A

0DataRank · unranked

60 citations

Jeff Zhao, Manqi Li, Yifang Dang, Evan Y. Yu, Jianfu Li +18 more

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

npj Precision Oncology(2024)10.1038/s41698-024-00599-6

N/A

0DataRank · unranked

32 citations

Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman, Navonil De Sarkar +24 more

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial

ESMO Open(2024)10.1016/j.esmoop.2024.103972

N/A

0DataRank · unranked

29 citations

M.D. Galsky, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Y. Loriot +19 more

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1728

N/A

0DataRank · unranked

7 citations

Gurkamal Chatta, Rohit K. Jain, Helen Moon, Scott E. Delacroix, Alana Fang +10 more

Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study

JCO Precision Oncology(2024)10.1200/po.23.00634

N/A

0DataRank · unranked

14 citations

George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C. Pritchard +13 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

Journal of Clinical Oncology(2024)10.1200/jco.23.02727

N/A

0DataRank · unranked

5 citations

Evan Y. Yu, Edwin M. Posadas, Richard J. Lee, Fatima Karzai, Peter L. Choyke +1 more

Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC).

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2024)10.17615/7y09-8d51

N/A

0DataRank · unranked

0 citations

Evan Y. Yu, Lauren C. Harshman, Nielsen, Matthew Edward, Yu‐Ning Wong, Andrew Z. Wang +14 more

Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci186599

N/A

0DataRank · unranked

10 citations

Roman Gulati, Erolcan Sayar, Radhika A. Patel, Micah Tratt, Helen Richards +40 more

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes

European Urology Oncology(2025)10.1016/j.euo.2025.01.002

N/A

0DataRank · unranked

6 citations

Abuzar Moradi Tuchayi, Soon Khai Low, Ali T. Arafa, Laura Graham, Roman Gulati +15 more

Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.769

N/A

0DataRank · unranked

2 citations

Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Aaron Lin, Brianna Woo +15 more

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

JAMA Oncology(2020)10.1001/jamaoncol.2020.5161

N/A

0DataRank · unranked

160 citations

Eric Q. Konnick, Michael T. Schweizer, Alexandra Sokolova, Petros Grivas, Heather H. Cheng +7 more

Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations

European Urology Focus(2025)10.1016/j.euf.2025.11.011

N/A

0DataRank · unranked

0 citations

Sam Callis, Evan Y. Yu, Scott E. Delacroix, Alexandra Sokolova, Catherine M. Tangen +4 more

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.10.002

N/A

0DataRank · unranked

19 citations

Sarah K. Holt, Ali Raza Khaki, Rishi Sekar, Adam J. Gadzinski, Yaw A. Nyame +17 more

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

PLoS ONE(2020)10.1371/journal.pone.0239686

N/A

0DataRank · unranked

10 citations

Rigo I. Acevedo, Daniel M. Lim, Roman Gulati, Agnes Gawne, Alexandra Sokolova +6 more

A pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the BRCA1/2 pathway.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.127

N/A

0DataRank · unranked

2 citations

Makayla DeJong, Evan Y. Yu, Roman Gulati, Matthew B. Rettig, Celestia S. Higano +4 more